Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
Initiative by National Health Authority aimed at accelerating automated claims processing under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana
Subscribe To Our Newsletter & Stay Updated